WO2001017510A1 - Mittel zur stimulanz der darmtätigkeit sowie verfahren zu dessen herstellung - Google Patents
Mittel zur stimulanz der darmtätigkeit sowie verfahren zu dessen herstellung Download PDFInfo
- Publication number
- WO2001017510A1 WO2001017510A1 PCT/EP2000/008647 EP0008647W WO0117510A1 WO 2001017510 A1 WO2001017510 A1 WO 2001017510A1 EP 0008647 W EP0008647 W EP 0008647W WO 0117510 A1 WO0117510 A1 WO 0117510A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- sponge
- intestine
- compound
- composition according
- agent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/734—Alginic acid
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
- A23L33/25—Synthetic polymers, e.g. vinylic or acrylic polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/717—Celluloses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/785—Polymers containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2063—Proteins, e.g. gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
Definitions
- Hydroxypropyl methyl cellulose phthalate HPMCP 55), hydroxypropyl methyl cellulose acetate succinate (Aqoat AS-MF. Aqoat AS-HF), 1: 1 Copolymer of methacrylic acid and ethyl arylate (Eudragit ® L), copolymer of vinyl acetate and crotonic acid (coating CE 5142), cellulose acetate phthalate (CAP, Aquateric), methacrylate copolymers (Eudragit ® S), shellac, Time Clock System ® , carnauba wax , Hydroxypropylmethyl cellulose (TC-5), Pulsincap ® , polyethylene glycol, cross-linked polyethylene glycol, ethyl cellulose, ethyl cellulose-ethanol mixture, hydroxypropyl cellulose, hydroxypropyl methyl cellulose, glycerol
- celulose derivatives in particular corresponding ethers, for example methyl cellulose, hydroxypropyl cellulose, hydroxypropyl methyl cellulose, or sodium carboxymethyl cellulose (preferably those compounds with a higher viscosity); natural (anionic) mucilages, for example xanthan gum, guar gum, tragacanth or alginic acid and salts thereof, and the like.
- natural (anionic) mucilages for example xanthan gum, guar gum, tragacanth or alginic acid and salts thereof, and the like.
- insoluble polysaccharides such as chitin or chitin derivatives or microcrystalline cellulose
- Linear high molecular weight polymers are particularly preferred according to the invention. Above all, according to the invention, such polymers can be used which have a fiber structure. Examples of such substances are the ski protein, such as keratins, conchagens, fibroins, elastins and collagen.
- connection is introduced into the sponge-like structure.
- This can e.g. can be achieved by watering. It is also conceivable that the connection is introduced into the sponge-like structure already during the production of the material by directly mixing the material and connection.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002383996A CA2383996A1 (en) | 1999-09-06 | 2000-09-05 | Agent for stimulating bowel function and method for producing the same |
EP00958522A EP1210070A1 (de) | 1999-09-06 | 2000-09-05 | Mittel zur stimulanz der darmtätigkeit sowie verfahren zu dessen herstellung |
AU70013/00A AU7001300A (en) | 1999-09-06 | 2000-09-05 | Agent for stimulating bowel function and method for producing the same |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE29915634U DE29915634U1 (de) | 1999-09-06 | 1999-09-06 | Mittel zur Stimulanz der Darmtätigkeit |
DE19942365.2 | 1999-09-06 | ||
DE19942365A DE19942365A1 (de) | 1999-09-06 | 1999-09-06 | Mittel zur Stimulanz der Darmtätigkeit sowie Verfahren zu dessen Herstellung |
DE29915634.6 | 1999-09-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2001017510A1 true WO2001017510A1 (de) | 2001-03-15 |
Family
ID=26054836
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2000/008647 WO2001017510A1 (de) | 1999-09-06 | 2000-09-05 | Mittel zur stimulanz der darmtätigkeit sowie verfahren zu dessen herstellung |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1210070A1 (de) |
AU (1) | AU7001300A (de) |
CA (1) | CA2383996A1 (de) |
WO (1) | WO2001017510A1 (de) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1296053C (zh) * | 2001-03-19 | 2007-01-24 | 宝洁公司 | 使用不能消化的聚合物泡沫来螯合摄取的物质从而抑制身体对这些物质的吸收 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3688763A (en) * | 1969-07-28 | 1972-09-05 | Raymond Cromarty | Diagnostic device and method |
WO1998009617A1 (de) * | 1996-09-07 | 1998-03-12 | Beisel Guenther | Mittel mit retardwirkung |
WO1998023259A1 (de) * | 1996-11-27 | 1998-06-04 | Beisel Guenther | Mittel zur erzeugung eines langanhaltenden sättigungseffekts |
EP0901792A1 (de) * | 1997-09-05 | 1999-03-17 | Dr. Suwelack Skin & Health Care AG | Mittel zur peroralen Verabreichung, seine Herstellung und Verwendung |
DE29915668U1 (de) * | 1999-09-06 | 2000-03-23 | Beisel Guenther | Mittel zur Verbesserung und Erhaltung der Darmtätigkeit |
DE29915656U1 (de) * | 1999-09-06 | 2000-04-20 | Beisel Guenther | Vernetztes Mittel zur Erzeugung eines langanhaltenden Sättigungseffekts |
-
2000
- 2000-09-05 AU AU70013/00A patent/AU7001300A/en not_active Abandoned
- 2000-09-05 CA CA002383996A patent/CA2383996A1/en not_active Abandoned
- 2000-09-05 WO PCT/EP2000/008647 patent/WO2001017510A1/de not_active Application Discontinuation
- 2000-09-05 EP EP00958522A patent/EP1210070A1/de not_active Withdrawn
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3688763A (en) * | 1969-07-28 | 1972-09-05 | Raymond Cromarty | Diagnostic device and method |
WO1998009617A1 (de) * | 1996-09-07 | 1998-03-12 | Beisel Guenther | Mittel mit retardwirkung |
WO1998023259A1 (de) * | 1996-11-27 | 1998-06-04 | Beisel Guenther | Mittel zur erzeugung eines langanhaltenden sättigungseffekts |
EP0901792A1 (de) * | 1997-09-05 | 1999-03-17 | Dr. Suwelack Skin & Health Care AG | Mittel zur peroralen Verabreichung, seine Herstellung und Verwendung |
DE29915668U1 (de) * | 1999-09-06 | 2000-03-23 | Beisel Guenther | Mittel zur Verbesserung und Erhaltung der Darmtätigkeit |
DE29915656U1 (de) * | 1999-09-06 | 2000-04-20 | Beisel Guenther | Vernetztes Mittel zur Erzeugung eines langanhaltenden Sättigungseffekts |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1296053C (zh) * | 2001-03-19 | 2007-01-24 | 宝洁公司 | 使用不能消化的聚合物泡沫来螯合摄取的物质从而抑制身体对这些物质的吸收 |
Also Published As
Publication number | Publication date |
---|---|
CA2383996A1 (en) | 2001-03-15 |
EP1210070A1 (de) | 2002-06-05 |
AU7001300A (en) | 2001-04-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60120413T2 (de) | Quervernetzte stark amylose haltige stärke zur verwendung in pharmazeutischen formulierungen mit kontrollierter freisetzung und verfahren zu ihrer herstellung | |
DE60026357T2 (de) | An- und abschwellende polymermischungen | |
Gyles et al. | A review of the designs and prominent biomedical advances of natural and synthetic hydrogel formulations | |
DE69814122T2 (de) | Darreichungsform zur verzögerten, vollständigen wirkstoffabgabe im verdauungstrakt | |
DE60016920T2 (de) | Arzneistoffverabreichungsystem zur verzögerten, völlstandigen wirkstoffabgabe im verdauungstrakt | |
Jones | Pharmaceutical applications of polymers for drug delivery | |
DE69914928T2 (de) | Polymerkomplexe von glukuronoglukanen | |
DE60025201T2 (de) | System für wirkstofffreisetzung im unteren verdauungstrakt | |
DE602005005062T2 (de) | Hyaluronsäure und alpha-, beta-polyaspartylhydrazidhydrogele und deren biomedizinischen und pharmazeutischen anwendungen | |
DE602004002908T2 (de) | Postchirurgische Antiadhäsionsschicht bestehend aus Carboxymethylchitosan und Carboxymethylcellulose und ihr Herstellungsverfahren | |
EP0631587A1 (de) | Vernetzte polysaccharide, verfahren zu ihrer herstellung und ihre verwendung | |
EP0485840B1 (de) | Orale Arzneiform und Überzugsmittel, enthaltend ein im Colon abbaubares Polysaccharid | |
DE60313296T2 (de) | Pharmazeutische darreichungsformen, welche einen tablettenkern mit einer bruchfestigkeit unter 38n/qcm und einen überzug zum schutz des weichen kerns enthalten | |
EP1209988B1 (de) | Vernetztes mittel zur erzeugung eines langanhaltenden sättigungseffekts und verfahren zu dessen herstellung | |
EP0948316B1 (de) | Mittel zur erzeugung eines langanhaltenden sättigungseffekts | |
DE69918104T2 (de) | Oral anwendbare zubereitungen enthaltend ein kationvernetztes polysaccharid und ein im unteren intestinalen bereich abbaubares polymer | |
DE2854651A1 (de) | Ueberzugsmittel fuer feste medikamente | |
EP2679216B1 (de) | Arzneiform zur modifizierten Freisetzung von Betahistin | |
DE19942417A1 (de) | Vernetztes Mittel zur Erzeugung eines langanhaltenden Sättigungseffekts und Verfahren zu dessen Herstellung | |
EP1210070A1 (de) | Mittel zur stimulanz der darmtätigkeit sowie verfahren zu dessen herstellung | |
DE19942365A1 (de) | Mittel zur Stimulanz der Darmtätigkeit sowie Verfahren zu dessen Herstellung | |
WO2000048577A1 (de) | Arzneimittel zur behandlung bzw. prävention von darmkrebs | |
DE60214154T2 (de) | Pharmazeutisches freigabekonstrukt zur magenretention | |
WO2001017509A1 (de) | Mittel zur verbesserung und erhaltung der darmtätigkeit sowie verfahren zu dessen herstellung | |
DE19942424A1 (de) | Mittel zur Verbesserung und Erhaltung der Darmtätigkeit sowie Verfahren zu dessen Herstellung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2000958522 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2383996 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10070673 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 2000958522 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2000958522 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: JP |